Overcoming the Declining Trends in Innovation and Investment in Cardiovascular Therapeutics

Eroom’s law (Moore’s law spelled backwards), describes adverse trends towards declining innovation and rising costs of drug development over the last several decades. Therapeutics for cardiovascular diseases (CVD) appear to have been particularly sensitive to these trends. Thirty-three percent fewer...

Full description

Bibliographic Details
Main Author: Gail A. Van Norman, MD
Format: Article
Language:English
Published: Elsevier 2017-10-01
Series:JACC: Basic to Translational Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2452302X17302231

Similar Items